The pharmacokinetics of the taxanes paclitaxel and docetaxel have been
studied extensively in humans. Paclitaxel has distinctly nonlinear ph
armacokinetics, with saturable distribution and elimination features.
Docetaxel pharmacokinetics are well described by linear processes, alt
hough some investigators detected subtle nonlinear characteristics. Cl
inically, nonlinear pharmacokinetics produce a disproportional relatio
nship between dose and drug exposure. This affects dose adjustments an
d calculation and use of dose intensity to compare chemotherapy regime
ns. Although the underlying mechanism of nonlinearity in paclitaxel di
sposition is not well understood, both metabolic and distributive proc
esses may be involved.